Literature DB >> 12832109

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine.

Kristine Mortensen1, Louise Lundby Christensen, Jens Juul Holst, Cathrine Orskov.   

Abstract

BACKGROUND: The incretin hormones GIP and GLP-1 are thought to be produced in separate endocrine cells located in the proximal and distal ends of the mammalian small intestine, respectively. METHODS AND
RESULTS: Using double immunohistochemistry and in situ hybridization, we found that GLP-1 was colocalized with either GIP or PYY in endocrine cells of the porcine, rat, and human small intestines, whereas GIP and PYY were rarely colocalized. Thus, of all the cells staining positively for either GLP-1, GIP, or both, 55-75% were GLP-1 and GIP double-stained in the mid-small intestine. Concentrations of extractable GIP and PYY were highest in the midjejunum [154 (95-167) and 141 (67-158) pmol/g, median and range, respectively], whereas GLP-1 concentrations were highest in the ileum [92 (80-207) pmol/l], but GLP-1, GIP, and PYY immunoreactive cells were found throughout the porcine small intestine.
CONCLUSIONS: Our results provide a morphological basis to suggest simultaneous, rather than sequential, secretion of these hormones by postprandial luminal stimulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12832109     DOI: 10.1016/s0167-0115(03)00125-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  93 in total

1.  A stereological evaluation of secretin and gastric inhibitory peptide-containing mucosal cells of the perinatal small intestine of the pig.

Authors:  C Van Ginneken; A Weyns
Journal:  J Anat       Date:  2004-10       Impact factor: 2.610

Review 2.  The role of incretin therapy at different stages of diabetes.

Authors:  Simona Cernea
Journal:  Rev Diabet Stud       Date:  2011-11-10

Review 3.  Diet: friend or foe of enteroendocrine cells--how it interacts with enteroendocrine cells.

Authors:  Sofia Moran-Ramos; Armando R Tovar; Nimbe Torres
Journal:  Adv Nutr       Date:  2012-01-05       Impact factor: 8.701

Review 4.  Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling.

Authors:  Charlotte C Ronveaux; Daniel Tomé; Helen E Raybould
Journal:  J Nutr       Date:  2015-02-04       Impact factor: 4.798

Review 5.  Effect of dairy proteins on appetite, energy expenditure, body weight, and composition: a review of the evidence from controlled clinical trials.

Authors:  Line Q Bendtsen; Janne K Lorenzen; Nathalie T Bendsen; Charlotte Rasmussen; Arne Astrup
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

Review 6.  Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA.

Authors:  Dorrin Zarrin Khat; Mansoor Husain
Journal:  Curr Diab Rep       Date:  2018-06-09       Impact factor: 4.810

Review 7.  Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.

Authors:  Ashok R Gunawardene; Bernard M Corfe; Carolyn A Staton
Journal:  Int J Exp Pathol       Date:  2011-04-25       Impact factor: 1.925

Review 8.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

Review 9.  Diversity of enteroendocrine cells investigated at cellular and subcellular levels: the need for a new classification scheme.

Authors:  Linda J Fothergill; John B Furness
Journal:  Histochem Cell Biol       Date:  2018-10-24       Impact factor: 4.304

10.  A major lineage of enteroendocrine cells coexpress CCK, secretin, GIP, GLP-1, PYY, and neurotensin but not somatostatin.

Authors:  Kristoffer L Egerod; Maja S Engelstoft; Kaare V Grunddal; Mark K Nøhr; Anna Secher; Ichiro Sakata; Jens Pedersen; Johanne A Windeløv; Ernst-Martin Füchtbauer; Jørgen Olsen; Frank Sundler; Jan P Christensen; Nils Wierup; Jesper V Olsen; Jens J Holst; Jeffrey M Zigman; Steen S Poulsen; Thue W Schwartz
Journal:  Endocrinology       Date:  2012-10-12       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.